Literature DB >> 11396879

Poly(2-hydroxyethyl methacrylate) film as a drug delivery system for pilocarpine.

G H Hsiue1, J A Guu, C C Cheng.   

Abstract

This work investigates pilocarpine trapped in a matrix diffusion-controlled drug delivery system using hydrophilic inserts of Poly(2-hydroxyethyl methacrylate) (pHEMA) to ensure an increased bioavailability of pilocarpine and prolong the length of time in which the medication remains in the eyes of the test subjects. The physical and chemical properties of pilocarpine were investigated to elucidate the mechanism of drug-polymer interaction and the effect on drug release behavior of controlled release polymeric devices. In vitro release studies indicated that pilocarpine continued to be released from the inserts for a 24 h period. The results of intraocular pressure tests performed on albino rabbits were consistent with the observed in vitro behavior. The pressure decrease was significant for a period longer than 48 h. It confirms that the inserts, as sustainable releasing devices, are promising carriers for ophthalmic drug delivery systems.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11396879     DOI: 10.1016/s0142-9612(00)00336-7

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  14 in total

1.  Poly(2-hydroxyethyl methacrylate) wound dressing containing ciprofloxacin and its drug release studies.

Authors:  Tai-Li Tsou; Shang-Tao Tang; Yu-Chuan Huang; Jing-Ran Wu; Jenn-Jong Young; Hsian-Jenn Wang
Journal:  J Mater Sci Mater Med       Date:  2005-02       Impact factor: 3.896

2.  A novel crosslinkable polymer as drug-loaded coating for biomedical device.

Authors:  Jian-Ping Xu; Jian Ji; Wei-Dong Chen; Hui-Fang Zhao; Jia-Cong Shen; De-Zeng Fan; Yu-Fu Sun
Journal:  J Mater Sci Mater Med       Date:  2004-02       Impact factor: 3.896

3.  Design and evaluation of novel fast forming pilocarpine-loaded ocular hydrogels for sustained pharmacological response.

Authors:  SivaNaga S Anumolu; Yashveer Singh; Dayuan Gao; Stanley Stein; Patrick J Sinko
Journal:  J Control Release       Date:  2009-03-31       Impact factor: 9.776

4.  Light-activated, in situ forming gel for sustained suprachoroidal delivery of bevacizumab.

Authors:  Puneet Tyagi; Matthew Barros; Jeffrey W Stansbury; Uday B Kompella
Journal:  Mol Pharm       Date:  2013-07-08       Impact factor: 4.939

5.  In vitro-ex vivo correlations between a cell-laden hydrogel and mucosal tissue for screening composite delivery systems.

Authors:  Anna K Blakney; Adam B Little; Yonghou Jiang; Kim A Woodrow
Journal:  Drug Deliv       Date:  2016-11       Impact factor: 6.419

6.  Wrinkle formation in a polymeric drug coating deposited via initiated chemical vapor deposition.

Authors:  Paul Christian; Heike M A Ehmann; Oliver Werzer; Anna Maria Coclite
Journal:  Soft Matter       Date:  2016-11-28       Impact factor: 3.679

7.  Controlling Indomethacin Release through Vapor-Phase Deposited Hydrogel Films by Adjusting the Cross-linker Density.

Authors:  Paul Christian; Stephan Tumphart; Heike M A Ehmann; Hans Riegler; Anna Maria Coclite; Oliver Werzer
Journal:  Sci Rep       Date:  2018-05-08       Impact factor: 4.379

8.  Characterization of the rheological, mucoadhesive, and drug release properties of highly structured gel platforms for intravaginal drug delivery.

Authors:  Gavin P Andrews; Louise Donnelly; David S Jones; Rhonda M Curran; Ryan J Morrow; A David Woolfson; R Karl Malcolm
Journal:  Biomacromolecules       Date:  2009-09-14       Impact factor: 6.988

9.  Biodegradable in situ gelling delivery systems containing pilocarpine as new antiglaucoma formulations: effect of a mercaptoacetic acid/N-isopropylacrylamide molar ratio.

Authors:  Jui-Yang Lai
Journal:  Drug Des Devel Ther       Date:  2013-10-24       Impact factor: 4.162

10.  Polymer Encapsulation of an Amorphous Pharmaceutical by initiated Chemical Vapor Deposition for Enhanced Stability.

Authors:  Paul Christian; Heike M A Ehmann; Anna Maria Coclite; Oliver Werzer
Journal:  ACS Appl Mater Interfaces       Date:  2016-08-09       Impact factor: 9.229

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.